Peer-reviewedCC BY 4.0Journal of Lipid Research
Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers
Related
- Sleep health and stroke risk: complementary analyses of CHARLS and the UK Biobank, including genetic susceptibility in the UK Biobank
- Lipoprotein(a) as a cardiovascular risk accelerator in primary prevention: Age-equivalent risk and event-free survival at 10 years in the UK biobank
- Characterization of circulating neoantigen-specific T cell responses and public T cell receptors shaping immune memory in Lynch syndrome carriers
- Lipoprotein(a) in Disaggregated South Asian Groups: An Analysis of MASALA and the UK Biobank.
- A multidimensional proteomic framework of circulating inflammation identifies outcome-specific cardiovascular risk axes in 39,494 UK biobank participants
BibTeX
@article{taleb2026antidepressant,
title = {{Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers}},
author = {Iosif Taleb and Courtney Astore and Kavita Praveen and Philip L.S.M. Gordts and Sotirios Tsimikas},
journal = {Journal of Lipid Research},
year = {2026},
month = oct,
doi = {10.1016/j.jlr.2026.101174},
url = {https://linkinghub.elsevier.com/retrieve/pii/S002222752600204X},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers
AU - Iosif Taleb
AU - Courtney Astore
AU - Kavita Praveen
AU - Philip L.S.M. Gordts
AU - Sotirios Tsimikas
PY - 2026
DA - 2026/10/01
JO - Journal of Lipid Research
DO - 10.1016/j.jlr.2026.101174
UR - https://linkinghub.elsevier.com/retrieve/pii/S002222752600204X
SN - 0022-2275
ER -